Amar Sawhney, PhD
Amar Sawhney, PhD
Amar Sawhney, PhD
CEO
Amar has been the President and CEO of many companies that have either gone public or been acquired by strategic partners. He holds over 120 patents which form the basis for several first-of-a-kind medical devices that have helped over 5 million patients worldwide. He has founded eight companies which account for over 4,000 jobs created and over $2 billion in revenue to date.
Nick Svencer
Amar Sawhney, PhD
Amar Sawhney, PhD
General Manager
Nick is a seasoned operations executive with strong analytical, organizational, technology, leadership, and relationship building competencies. Before Pramand, Nick was VP of Operations at Augmenix through its successful exit. He was also previously at Brontes Technologies (a 3M company), Confluent Surgical, and Analogic Corporation.
Mike Bassett
Amar Sawhney, PhD
Christina Young
Head of Research & Development
Mike has 20+ years of medical device development experience focused mainly in hydrogel technology. He has held development roles of increasing responsibility through Focal Therapeutix, Confluent Surgical, Ocular Therapeutix and most recently Access Vascular where he was the Co-founder and Chief Scientific Officer.
Christina Young
Christina Young
Christina Young
Head of Operations & Manufacturing
Christina is an experienced operations manager with strong problem-solving, critical thinking, and communication skills. Before Pramand, Christina was Senior Director, Manufacturing at Ocular Therapeutix where she managed late-stage clinical development and commercial manufacturing. She was previously at Confluent Surgical.
Dan Phelan
Christina Young
Dan Phelan
Head of Regulatory and Quality
Dan is a business-oriented regulatory professional with over 25 years of experience gaining market approval and clearance for a variety of medical devices via both the 510(k) and PMA process. Prior to Pramand, he held roles at Bose, Portal Instruments, and Hologic.